Enovis reported $579.91M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Alcidion AUD 23.27M 565K Dec/2025
Ambu A/S DKK 1.4B 6M Mar/2026
Amplifon EUR 526.12M 613K Jun/2026
Apollo Hospitals Enterprise Ltd INR 57.31B 1.51B Dec/2025
Coloplast 5.19B 185M Dec/2025
Convatec Group USD 1B 518M Dec/2024
Diasorin EUR 231M 511K Mar/2026
Enovis USD 579.91M 6.59M Mar/2026
Gulf Medical Proj AED 168.72M 14.25M Mar/2026
Hoya 174.48B 2.66B Mar/2026
Med Life RON 809.23M 61.36M Mar/2026
Oriola-kd EUR 45.4M 451.2M Mar/2026
Rede D'or Sao Luiz BRL 11.43B 385.31M Mar/2026
Siemens Healthineers EUR 4.82B 137M Jun/2026
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 167.61M 83.39M Mar/2026